Background

 

HIV.AIDS is known to destroy the body's immune system producing several complications one of which is lypodystrophy. Most anti-retroviral drugs especially the potease inhibitors are lypodystrophic. This constitutes a dual predisposition to cardiovascular disorders.

 

A positive correction has been established between the development of lypodystrophic, cardiac abnormalities and raised plasma TCH and LDL and a negative one with raised HDL.